Chronic Cutaneous Lupus Erythematosus

  • Michael Sticherling


Systemic Lupus Erythematosus Lichen Planus Cutaneous Lupus Erythematosus Discoid Lupus Erythematosus Subacute Cutaneous Lupus Erythematosus 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ackerman AB (1997) Lupus erythematosus. In: Ackerman AB (ed) Histologic diagnosis of inflammatory skin diseases. 2nd ed. Williams & Wilkins, Baltmore pp 525–546Google Scholar
  2. Asghar SS, Venneker GT, van Meegen M, Meinardi MM, Hulsmans RF, de Waal LP (1991) Hereditary deficiency of C5 in association with discoid lupus erythematosus. J Am Acad Dermatol 24: 376–378PubMedGoogle Scholar
  3. Baima B, Sticherling M (2001) Apoptosis in different manifestations of cutaneous lupus erythematosus. Br J Dermatol 144: 958–966PubMedGoogle Scholar
  4. Botella R, Alfonso R, Silvestre JF, Ramon R (1999) Discoid lupus erythematosus-like lesions and stomatitis. Arch Dermatol 135: 847, 850Google Scholar
  5. Bottomley WW, Goodfield MJ (1995) Methotrexate for the treatment of discoid lupus erythe-matosus. Br J Dermatol 133: 655–656PubMedGoogle Scholar
  6. Burge SM, Frith PA, Juniper RP, Wojnarowska F (1989) Mucosal involvement in systemic and chronic cutaneous lupus erythematosus. Br J Dermatol 121: 727–741PubMedGoogle Scholar
  7. Callen JP (2002) Management of skin disease in patients with lupus erythematosus. Best Pract Res Clin Rheumatol 16: 245–264CrossRefPubMedGoogle Scholar
  8. Caproni M, Palleschi GM, Papi C, Fabbri P (1995) Discoid lupus erythematosus lesions developed on lupus erythematosus profundus nodules. Int J Dermatol 34: 357–359PubMedGoogle Scholar
  9. Cardinali C, Caproni M, Fabbri P (1999) The utility of the lupus band test on sun-protected non-lesional skin for the diagnosis of systemic lupus erythematosus. Clin Exp Rheumatol 17: 427–432PubMedGoogle Scholar
  10. Casciola-Rosen LA, Anhalt G, Rosen A (1994) Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 179: 1317–1330CrossRefPubMedGoogle Scholar
  11. Casiano C, Wu X, Molinaro C (2000) Apoptosis, necrosis, and the genesis of antinuclear antibodies. in: Conrad K, Humbel RL, Meurer M, Shoenfeld Y, Tan EM (eds) Autoantigens and autoantibodies: diagnostic tool and clues to understanding autoimmunity. Pabst Science Publishers, Lengerich, pp 152–186Google Scholar
  12. Chambers CA (2003) Topical tacrolimus for cutaneous lupus erythematosus. Br J Dermatol 148: 829CrossRefGoogle Scholar
  13. de Berker D, Dean D, Leigh IM, Burge S (1995) Keratin expression in discoid lupus erythematosus. Exp Dermatol 4: 350–356PubMedGoogle Scholar
  14. de Jong EM, van der Vleuten CJ, van Vlijmen-Willems IM (1997) Differences in extracellular matrix proteins, epidermal growth and differentiation in discoid lupus erythematosus, lichen planus and the overlap syndrome. Acta Derm Venereol 77: 356–360PubMedGoogle Scholar
  15. de la Rosa Carrillo D, Christensen OB (2004) Treatment of chronic discoid lupus erythematosus with topical tacrolimus. Acta Derm Venereol. 84: 233–234CrossRefPubMedGoogle Scholar
  16. Dekle CL, Mannes KD, Davis LS, Sangueza OP (1999) Lupus tumidus. J Am Acad Dermatol 41: 250–253PubMedGoogle Scholar
  17. Denfeld RW, Kind P, Sontheimer RD, Schöpf E, Simon JC (1997) In situ expression of B7 and CD28 receptor families in skin lesions of patients with lupus erythematosus. Arthritis Rheum 40: 814–821PubMedGoogle Scholar
  18. Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, Lewis CW, Pariser DM, Skouge JW, Webster SB, Whitaker DC, Butler B, Lowery BJ, Sontheimer RD, Callen JP, Camisa C, Provost TT, Tuffanelli DL (1996) Guidelines of care for cutaneous lupus erythematosus. American Academy of Dermatology. J Am Acad Dermatol 34: 830–836CrossRefPubMedGoogle Scholar
  19. Edwards KR, Burke WA (1999) Treatment of localized discoid lupus erythematosus with tazarotene. J Am Acad Dermatol 41: 1049–1050PubMedGoogle Scholar
  20. Fisher DA, Everett MA (1996) Violaceous rash of dorsal fingers in a woman. Diagnosis: chilblain lupus erythematosus (perniosis). Arch Dermatol 132: 459–462CrossRefPubMedGoogle Scholar
  21. Furst DE (1999) Leflunomide, mycophenolic acid and matrix metalloproteinase inhibitors. Rheumatology (Oxford) 38: 14–18CrossRefGoogle Scholar
  22. Furukawa F, Tokura Y, Matsushita K, Iwasaki-Inuzuka K, Onagi-Suzuki K, Yagi H, Wakita H, Takigawa M (1996) Selective expansions of T cells expressing V beta 8 and V beta 13 in skin lesions of patients with chronic cutaneous lupus erythematosus. J Dermatol 23: 670–676PubMedGoogle Scholar
  23. Gallego H, Crutchfield CE 3rd, Lewis EJ, Gallego HJ (1999) Report of an association between discoid lupus erythematosus and smoking. Cutis 63: 231–234Google Scholar
  24. Garcia-Porrua C, Gonzales-Gay MA, Fernandez-Lamelo F, Paz-Carreira JM, Lavilla E, Gonzales-Lopez MA (1998) Simultaneous development of SLE-like syndrome and autoimmune thyroiditis following alpha-interferon treatment. Clin Exp Rheumatol 16: 107–108PubMedGoogle Scholar
  25. Georgala S, Katoulis AC, Hasapi V, Koumantaki-Mathioudaki E (1998) Thalidomide treatment for hypertrophic lupus erythematosus. Clin Exp Dermatol 23: 141CrossRefPubMedGoogle Scholar
  26. George R, Kurian S, Jacob M, Thomas K (1995) Diagnostic evaluation of the lupus band test in discoid and systemic lupus erythematosus. Int J Dermatol 34: 170–173PubMedGoogle Scholar
  27. Gescuk BD, Davis JC Jr. (2002) Novel therapeutic agents for systemic lupus erythematosus. Curr Opin Rheumatol 14: 515–521CrossRefPubMedGoogle Scholar
  28. Golan TD, Sigal D, Sabo E, Shemuel Z, Guedj D, Weinberger A (1997) The penetrating potential of autoantibodies into live cells in vitro coincides with the in vivo staining of epidermal nuclei. Lupus 6: 18–26PubMedGoogle Scholar
  29. Hasan T, Stephansson E, Ranki A (1999) Distribution of naive and memory T-cells in photoprovoked and spontaneous skin lesions of discoid lupus erythematosus and polymorphous light eruption. Acta Derm Venereol 79: 437–442CrossRefPubMedGoogle Scholar
  30. Isenberg D, Leckie MJ (2002) Biological treatments for systemic lupus erythematosus. Scand J Rheumatol 31:187–191CrossRefPubMedGoogle Scholar
  31. Jacob CO (1992) Tumor necrosis factor and interferon gamma: relevance for immune regulation and genetic predisposition to autoimmune disease. Semin Immunol 4: 147–154PubMedGoogle Scholar
  32. Jayne D (1999) Non-transplant uses of mycophenolate mofetil. Curr Opin Nephrol Hypertens 8: 563–567CrossRefPubMedGoogle Scholar
  33. Jewell ML, McCauliffe DP (2000) Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment. J Am Acad Dermatol 42: 983–987CrossRefPubMedGoogle Scholar
  34. Kanda N, Tsuchida T, Watanabe T, Tamaki K (1996) Clinical features of systemic lupus erythematosus in men. Characteristics of the cutaneous manifestations. Dermatology 193: 6–10PubMedGoogle Scholar
  35. Kanda N, Tsuchida T, Watanabe T, Tamaki K (1997) Cutaneous lupus mucinosis: a review of our cases and the possible pathogenesis. J Cutan Pathol 24: 553–558PubMedGoogle Scholar
  36. Kind P, Lehmann P, Plewig G (1993) Phototesting in lupus erythematosus. J Invest Dermatol 100: 53S–57SCrossRefPubMedGoogle Scholar
  37. Kuhn A, Sonntag M, Richter-Hintz D, Oslislo C, Megahed M, Ruzicka T, Lehmann P (2001) Phototesting in lupus erythematosus: a 15-year experience. J Am Acad Dermatol 45: 86–95CrossRefPubMedGoogle Scholar
  38. Kuhn A, Specker C, Ruzicka T, Lehmann P (2002) Methotrexate treatment for refractory subacute cutaneous lupus erythematosus. J Am Acad Dermatol 46: 600–603CrossRefPubMedGoogle Scholar
  39. Kuhn A, Sonntag M, Ruzicka T, Lehmann P, Megahed M (2003) Histopathologic findings in lupus erythematosus tumidus: review of 80 patients. J Am Acad Dermatol 48: 901–908CrossRefPubMedGoogle Scholar
  40. Kundig TM, Trueb RM, Krasovec M (1997) Lupus profundus/panniculitis. Dermatology 195: 99–101PubMedGoogle Scholar
  41. Kyriakis KP, Kontochristopoulos GJ, Panteleos DN (2000) Experience with low-dose thalidomide therapy in chronic discoid lupus erythematosus. Int J Dermatol 39: 218–222CrossRefPubMedGoogle Scholar
  42. Magro CM, Crowson AN, Harrist TJ (1996) The use of antibody to C5b-9 in the subclassification of lupus erythematosus. Br J Dermatol 134: 855–862CrossRefPubMedGoogle Scholar
  43. Marks R (1995) Lichen planus and cutaneous lupus erythematosus. in: Lowe N, Marks R (eds) Retinoids. A clinician’s guide. Martin Dunitz, London, pp 113–117Google Scholar
  44. Martens PB, Moder KG, Ahmed I (1999) Lupus panniculitis: clinical perspectives from a case series. J Rheumatol 26: 68–72PubMedGoogle Scholar
  45. McCauliffe DP (1998) Distinguishing subacute cutaneous from other types of lupus erythematosus. Lancet 351: 1527–1528CrossRefPubMedGoogle Scholar
  46. Middleton MH, Norris DA (1995) Cytokine-induced ICAM-1 expression in human keratinocytes is highly variable in keratinocyte strains from different donors. J Invest Dermatol 104: 489–496CrossRefPubMedGoogle Scholar
  47. Millard TP, Hawk JLM (2001) Ultraviolet therapy in lupus. Lupus 10: 185–187PubMedGoogle Scholar
  48. Molin L (1999) Discoid lupus erythematosus lesions treated with cryosurgery. Adv Exp Med Biol 455: 375–376PubMedGoogle Scholar
  49. Mond CB, Peterson MG, Rothfield NF (1989) Correlation of anti-Ro antibody with photosensitivity rash in systemic lupus erythematosus patients. Arthritis Rheum 32: 202–204PubMedGoogle Scholar
  50. Norris DA, Bennion SD, David-Bajar K (1996) Pathomechanisms of cutaneous lupus erythe-matosus. In: Wallace DJ, Hahn BH (eds) Dubois’ Lupus Erythematosus. 4th ed. Lea and Fiebiger, Philadelphia, pp 549–567Google Scholar
  51. Nousari HC, Kimyai-Asadi A, Provost TT (1999) Generalizedlupus erythematosus profundus in a patient with genetic partial deficiency of C4. J Am Acad Dermatol 41: 362–364PubMedGoogle Scholar
  52. Nunez M, Boixeda P, Miralles ES, de Misa RF, Ledo A (1996) Pulsed dye laser treatment of teleangiectatic chronic erythema of cutaneous lupus erythematosus. Arch Dermatol 132: 354–355CrossRefPubMedGoogle Scholar
  53. Nurnberg W, Algermissen B, Hermes B, Henz BM, Kolde G (1996) Erfolgreiche Behandlung des chronisch-diskoiden Lupus erythematodes mit dem Argon Laser. Hautarzt 47: 767–770CrossRefPubMedGoogle Scholar
  54. Ochsendorf FR, Runne U (1996) Chloroquine: consideration of maximum daily dose (3.5 mg/kg ideal body weight) prevents retinopathy. Dermatology 192: 382–383PubMedGoogle Scholar
  55. Ordi J, Cortes F, Martinez N, Maurin M, De Torres I, Vilardell M (1998) Thalidomide induces amenorrhea in patients with lupus disease. Arthritis Rheum 41: 2273–2275CrossRefPubMedGoogle Scholar
  56. Ordi-Ros J, Cortes F, Cucurull E, Maurin M, Bujan S, Vilardell M (2000) Thalidomide in the treatment of cutaneous lupus refractory to conventional therapy. J Rheumatol 27: 1429–1433PubMedGoogle Scholar
  57. Parodi A, Rebora A (1997) ARA and EADV criteria for classification of systemic lupus erythematosus in patients with cutaneous lupus erythematosus. Dermatology 194: 217–220PubMedGoogle Scholar
  58. Parodi A, Massone C, Cacciapuoti M, Aragone MG, Bondavalli P, Cattarini G, Rebora A (2000) Measuring the activity of the disease in patients with cutaneous lupus erythematosus. Br J Dermatol 142: 457–460CrossRefPubMedGoogle Scholar
  59. Patel PP, Werth V (2002) Cutaneous lupus erythematosus: a review. Dermatol Clin 20: 373–385CrossRefPubMedGoogle Scholar
  60. Perniciaro C, Randle HW, Perry HO (1995). Hypertrophic discoid lupus erythematosus resembling squamous cell carcinoma. Dermatol Surg 21: 255–257CrossRefPubMedGoogle Scholar
  61. Prinz JC, Meurer M, Reiter C, Rieber EP, Plewig G, Riethmuller G (1996) Treatment of severe cutaneous lupus erythematosus with a chimeric CD4 monoclonal antibody, cM-T412. J Am Acad Dermatol 34: 244–252PubMedGoogle Scholar
  62. Provost TT, Watson R, Simmons-O’Brien E (1996) Significance of the anti-Ro (SS-A) antibody in evaluation of patients with cutaneous manifestations of a connective tissue disease. J Am Acad Dermatol 35: 147–169CrossRefPubMedGoogle Scholar
  63. Richter HI, Krutmann J, Goerz G (1998) Extrakorporale Photopherese bei therapie-refraktärem disseminiertem diskoiden Lupus erythematodes. Hautarzt 49: 487–491CrossRefPubMedGoogle Scholar
  64. Ruffatti A, Veller-Fornasa C, Patrassi GM, Sartori E, Tonello M, Tonetto S, Peserico A, Todesco S (1995) Anticardiolipin antibodies and antiphospholipid syndrome in chronic discoid lupus erythematosus. Clin Rheumatol 14: 402–404PubMedGoogle Scholar
  65. Ruiz H, Sanchez JL (1999) Tumid lupus erythematosus. Am J Dermatopathol 21: 356–360CrossRefPubMedGoogle Scholar
  66. Rupec RA, Petropoulou T, Belohradsky BH, Walchner M, Liese JG, Plewing G, Messer G (2000) Lupus erythematosus tumidus and chronic discoid lupus erythematosus in carriers of X-linked chronic granulomatous disease. Eur J Dermatol 10: 184–189PubMedGoogle Scholar
  67. Sabbagh N, Delaporte E, Marez D, Lo-Guidice JM, Piette F, Broly F (1997) NAT2 genotyping and efficacy of sulfasalazine in patients with chronic discoid lupus erythematosus. Pharmacogenetics 7: 131–135PubMedGoogle Scholar
  68. Saeki Y, Ohshima S, Kurimoto I, Miura H, Suemura M (2000) Maintaining remission of lupus erythematosus profundus (LEP) with cyclosporin A. Lupus 9: 390–392CrossRefPubMedGoogle Scholar
  69. Sonntag M, Lehmann P, Megahed M, Ruzicka T, Kuhn A (2003) Papulonodular mucinosis associated with subacute cutaneous lupus erythematosus. Dermatology 206: 326–329CrossRefPubMedGoogle Scholar
  70. Sontheimer RD, Bergstresser PR (1982) Epidermal Langerhans cell involvement in cutaneous lupus erythematosus. J Invest Dermatol 79: 237–243CrossRefPubMedGoogle Scholar
  71. Sontheimer RD, Provost TT (1996) Lupus erythematosus. in: Sontheimer RD, Provost TT: Cutaneous manifestations of rheumatic diseases. William & Wilkins, Baltimore, pp 1–71Google Scholar
  72. Stein LF, Saed GM, Fivenson DP (1997) T-cell cytokine network in cutaneous lupus erythematosus. J Am Acad Dermatol 36: 191–196PubMedGoogle Scholar
  73. Su WP, Perniciaro C, Rogers RS 3rd, White JW Jr (1994) Chilblain lupus erythematosus (lupus pernio): clinical review of the Mayo Clinic experience and proposal of diagnostic criteria. Cutis 54: 395–399PubMedGoogle Scholar
  74. Talbot JH (1993) Historical background of discoid and systemic lupus erythematosus. In: Wallace DJ, Hahn BH (eds) Dubois’ Lupus Erythematosus. 4th ed. Lea and Fiebiger, Philadelphia, pp 3–12Google Scholar
  75. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271–1277PubMedGoogle Scholar
  76. Tan EM (1994) Autoimmunity and apoptosis. J Exp Med 179: 1083–1086PubMedGoogle Scholar
  77. Tebbe B, Mansmann U, Wollina U, Auer-Grumbach P, Licht-Mbalyohere A, Arensmeier M, Orfanos CE (1997) Markers in cutaneous lupus erythematosus indicating systemic involvement. A multicenter study on 296 patients. Acta Derm Venereol 77: 305–308PubMedGoogle Scholar
  78. Thivolet J, Nicolas JF, Kanitakis J, Lyonnet S, Chouvet B (1990) Recombinant interferon alpha 2a is effective in the treatment of discoid and subacute cutaneous lupus erythematosus. Br J Dermatol 122: 405–409PubMedGoogle Scholar
  79. Ting WW, Sontheimer RD (2001) Local therapy for cutaneous and systemic lupus erythematosus: practical and theoretical considerations. Lupus 10: 171–184CrossRefPubMedGoogle Scholar
  80. Uy HS, Pineda R 2nd, Shore JW, Polcharoen W, Jakobiec FA, Foster CS (1999) Hypertrophic discoid lupus erythematosus of the conjunctiva. Am J Ophthalmol 127: 604–605CrossRefPubMedGoogle Scholar
  81. Volc-Platzer B, Anegg B, Milota S, Pickl W, Fischer G (1993) Accumulation of gamma delta T cells in chronic cutaneous lupus erythematosus. J Invest Dermatol 100: 84S–91SCrossRefPubMedGoogle Scholar
  82. Walker SL, Harland CC (2000) Carbon dioxide laser resurfacing of facial scarring secondary to chronic discoid lupus erythematosus. Br J Dermatol 143: 1101–1102CrossRefPubMedGoogle Scholar
  83. Walker SL, Kirby B, Chalmers RJ. (2002) The effect of topical tacrolimus on severe recalcitrant chronic discoid lupus erythematosus. Br J Dermatol 147: 405–6CrossRefPubMedGoogle Scholar
  84. Wallace DJ (2002) Management of lupus erythematosus: recent insights. Curr Opin Rheumatol 14: 212–219CrossRefPubMedGoogle Scholar
  85. Warren KJ, Nopper AJ, Crosby DL (1998) Thalidomide for recalcitrant discoid lesions in a patient with systemic lupus erythematosus. J Am Acad Dermatol 39: 293–295PubMedGoogle Scholar
  86. Watanabe T, Tsuchida T (1995) Classification of lupus erythematosus based upon cutaneous manifestations. Dermatological, systemic and laboratory findings in 191 patients. Dermatology 190: 277–283PubMedGoogle Scholar
  87. Watanabe T, Tsuchida T (1996) Lupus erythematosus profundus: a cutaneous marker for a distinct clinical subset? Br J Dermatol 134: 123–125CrossRefPubMedGoogle Scholar
  88. Watanabe T, Tsuchida T, Ito Y, Kanda N, Ueda Y, Tamaki K (1997) Annular erythema associated with lupus erythematosus/Sjogren’s syndrome. J Am Acad Dermatol 36: 214–218PubMedGoogle Scholar
  89. Williams WL, Ramos-Caro FA (1999) Acute periorbital mucinosis in discoid lupus erythematosus. J Am Acad Dermatol 41: 871–873PubMedGoogle Scholar
  90. Wollina U, Looks A (1999) Extracorporeal photochemotherapy in cutaneous lupus erythematosus. J Eur Acad Dermatol Venereol. 13: 127–130CrossRefPubMedGoogle Scholar
  91. Wozel G (1996) Dapson — Pharmakologie, Wirkmechanismus und klinischer Einsatz. Thieme Stuttgart, New York 1996Google Scholar

Copyright information

© Springer-Verlag Wien 2005

Authors and Affiliations

  • Michael Sticherling

There are no affiliations available

Personalised recommendations